BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7425599)

  • 1. In vitro and in vivo antimicrobial activities of sporaricin A, a new aminoglycoside.
    Kobayashi F; Saino Y; Koshi T; Hattori Y
    Antimicrob Agents Chemother; 1980 Mar; 17(3):337-43. PubMed ID: 7425599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.
    Saino Y; Hattori Y; Koshi T; Kobayashi F; Oda T; Mitsuhashi S
    Antimicrob Agents Chemother; 1984 Aug; 26(2):187-91. PubMed ID: 6548350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
    Neu HC; Fu KP
    J Antibiot (Tokyo); 1978 May; 31(5):385-93. PubMed ID: 27494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
    Inouye S; Hara T; Matsuhashi Y; Kitasato I
    Drugs Exp Clin Res; 1989; 15(10):455-63. PubMed ID: 2632214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparison of dibekacin and gentamicin activities.
    Hill CD; Counts GW; Turck M
    Antimicrob Agents Chemother; 1981 Jan; 19(1):190-2. PubMed ID: 6787978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
    Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
    Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
    Kabins SA; Nathan C; Cohen S
    Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of netilmicin, gentamicin, and amikacin.
    Kantor RJ; Norden CW
    Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
    Okubo T; Iyobe S
    Jpn J Antibiot; 2002 Oct; 55(5):514-23. PubMed ID: 12532635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
    O'Hara K; Nakamura A; Sawai T; Hosino K; Iwai Y; Nakamura S; Seto I
    Jpn J Antibiot; 2000 Jan; 53(1):46-59. PubMed ID: 10709145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antibacterial activities of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with those of other aminoglycoside antibiotics.
    Matsuhashi Y; Yoshida T; Hara T; Kazuno Y; Inouye S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):589-94. PubMed ID: 3873901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.